ELOVL2 and breast carcinoma: First, the analysis of a previous microarray dataset consisting of 51 breast cancer cell lines (44) showed a significant attenuation of ELOVL2 expression in basal-like breast cancer cell lines associated with EMT (Basal A and Basal B) (45) compared to luminal breast cancer cell lines (Figure 4A).